EWG Report || BodyBurden 2 - The Pollution in Newborns
287 toxins found in the cord blood of newborns! We are up against the plague of environmental toxins from before birth. Detoxifying on an ongoing basis is critical to health.
Cryo-Cell, a private cord blood bank in business since 1992, has been very active in stem cell research and development. In 2007 C’elle was introduced, a service that enables women to collect and preserve stem cells from their menstrual blood. Stem cells found in menstrual blood may potentially be useful in future therapies to treat a number of debilitating conditions such as heart disease, stroke and diabetes. They also have the potential to be used in regenerative medicine and even cosmeceutical applications such as anti-aging and sports medicine. Stem cell research and development is growing rapidly, and within the past few weeks, Cryo-Cell announced several new initiatives for C’elle. These include research and development initiatives in China and also in Brazil, where scientists will study diagnostic and therapeutic uses for endometriosis and stress urinary incontinence in women. Here in the U.S., they’re collaborating with a renowned expert in wound healing. Read more about the latest news and advancements from C'elle here in this recent interview with Cryo-Cell CEO Mercedes Walton: http://bit.ly/4hwTZ.
-- Ryan Smith, Cryo-Cell Associate www.celle.com, www.cryo-cell.com>
2 comments:
Cryo-Cell, a private cord blood bank in business since 1992, has been very active in stem cell research and development. In 2007 C’elle was introduced, a service that enables women to collect and preserve stem cells from their menstrual blood. Stem cells found in menstrual blood may potentially be useful in future therapies to treat a number of debilitating conditions such as heart disease, stroke and diabetes. They also have the potential to be used in regenerative medicine and even cosmeceutical applications such as anti-aging and sports medicine.
Stem cell research and development is growing rapidly, and within the past few weeks, Cryo-Cell announced several new initiatives for C’elle. These include research and development initiatives in China and also in Brazil, where scientists will study diagnostic and therapeutic uses for endometriosis and stress urinary incontinence in women. Here in the U.S., they’re collaborating with a renowned expert in wound healing. Read more about the latest news and advancements from C'elle here in this recent interview with Cryo-Cell CEO Mercedes Walton: http://bit.ly/4hwTZ.
-- Ryan Smith, Cryo-Cell Associate
www.celle.com, www.cryo-cell.com>
Ryan, thanks for the post. You don't leave any direct contact info, but if you see this please consider subscribing to TIHL!
Post a Comment